"Cell Cycle" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE.
| Descriptor ID |
D002453
|
| MeSH Number(s) |
G04.144
|
| Concept/Terms |
Cell Cycle- Cell Cycle
- Cell Cycles
- Cycle, Cell
- Cycles, Cell
- Cell Division Cycle
- Cell Division Cycles
- Cycle, Cell Division
- Cycles, Cell Division
- Division Cycle, Cell
- Division Cycles, Cell
|
Below are MeSH descriptors whose meaning is more general than "Cell Cycle".
Below are MeSH descriptors whose meaning is more specific than "Cell Cycle".
This graph shows the total number of publications written about "Cell Cycle" by people in this website by year, and whether "Cell Cycle" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2002 | 1 | 1 | 2 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 1 | 2 |
| 2006 | 1 | 1 | 2 |
| 2007 | 1 | 0 | 1 |
| 2009 | 0 | 2 | 2 |
| 2010 | 0 | 3 | 3 |
| 2011 | 0 | 2 | 2 |
| 2012 | 0 | 2 | 2 |
| 2013 | 1 | 1 | 2 |
| 2014 | 0 | 4 | 4 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 3 | 4 |
| 2017 | 9 | 40 | 49 |
| 2018 | 4 | 34 | 38 |
| 2019 | 2 | 16 | 18 |
| 2020 | 0 | 3 | 3 |
| 2021 | 1 | 3 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Cell Cycle" by people in Profiles.
-
Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-Celecoxib. Biomolecules. 2021 07 16; 11(7).
-
ROS/RNS Balancing, Aerobic Fermentation Regulation and Cell Cycle Control - a Complex Early Trait ('CoV-MAC-TED') for Combating SARS-CoV-2-Induced Cell Reprogramming. Front Immunol. 2021; 12:673692.
-
3-Alkenyl-2-oxindoles: Synthesis, antiproliferative and antiviral properties against SARS-CoV-2. Bioorg Chem. 2021 09; 114:105131.
-
Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell. Cell Rep. 2021 07 13; 36(2):109364.
-
The role of mediator complex subunit 19 in human diseases. Exp Biol Med (Maywood). 2021 08; 246(15):1681-1687.
-
To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis. Front Immunol. 2021; 12:653974.
-
Lysosome activation in peripheral blood mononuclear cells and prognostic significance of circulating LC3B in COVID-19. Brief Bioinform. 2021 03 22; 22(2):1466-1475.
-
MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents? Cell Cycle. 2021 01; 20(2):143-153.
-
Cyclin dependent kinase inhibitors as a new potential therapeutic option in management of COVID-19. Med Hypotheses. 2021 01; 146:110380.
-
Consensus transcriptional regulatory networks of coronavirus-infected human cells. Sci Data. 2020 09 22; 7(1):314.